Exosomes of adult human fibroblasts cultured on 3D silk fibroin nonwovens intensely stimulate neoangiogenesis
- Burns & Trauma Vol. 9, Issue 1, (2021)
- 作者机构：
1. Human Histology & Embryology Section
2. University of Verona Medical School
3. Department of Burns & Plastic Surgery, The Affiliated Hospital of ZunYi Medical University
4. Department of Burns and Plastic Surgery
5. University of Shenzhen
6. Silk Biomaterials S..l,r
- 作者简介：
- 基金信息：
DOI：10.1093/burnst/tkab003
CLC：Published：2021，
Published Online：4 May 2021，
扫 描 看 全 文
Peng Hu, Anna Chiarini, Jun Wu, Giuliano Freddi, Kaiyu Nie, Ubaldo Armato, Ilaria Dal Prà, Exosomes of adult human fibroblasts cultured on 3D silk fibroin nonwovens intensely stimulate neoangiogenesis, Burns & Trauma, Volume 9, 2021, tkab003, https://doi.org/10.1093/burnst/tkab003
摘要
Abstract
BackgroundBombyx mori silk fibroin is a biomacromolecule that allows the assembly of scaffolds for tissue engineering and regeneration purposes due to its cellular adhesiveness
high biocompatibility and low immunogenicity. Earlier work showed that two types of 3D silk fibroin nonwovens (3D-SFnws) implanted into mouse subcutaneous tissue were promptly vascularized via undefined molecular mechanisms. The present study used nontumorigenic adult human dermal fibroblasts (HDFs) adhering to a third type of 3D-SFnws to assess whether HDFs release exosomes whose contents promote neoangiogenesis.MethodsElectron microscopy imaging and physical tests defined the features of the novel carded/hydroentangled 3D-SFnws. HDFs were cultured on 3D-SFnws and polystyrene plates in an exosome-depleted medium. DNA amounts and D-glucose consumption revealed the growth and metabolic activities of HDFs on 3D-SFnws. CD9-expressing total exosome fractions were from conditioned media of 3D-SFnws and 2D polystyrene plates HDF cultures. Angiogenic growth factors (AGFs) in equal amounts of the two groups of exosomal proteins were analysed via double-antibody arrays. A tube formation assay using human dermal microvascular endothelial cells (HDMVECs) was used to evaluate the exosomes’ angiogenic power.ResultsThe novel features of the 3D-SFnws met the biomechanical requirements typical of human soft tissues. By experimental day 15
3D-SFnws-adhering HDFs had increased 4.5-fold in numbers and metabolized 5.4-fold more D-glucose than at day 3 in vitro. Compared to polystyrene-stuck HDFs
exosomes from 3D-SFnws-adhering HDFs carried significantly higher amounts of AGFs
such as interleukin (IL)-1α
IL-4 and IL-8; angiopoietin-1 and angiopoietin-2; angiopoietin-1 receptor (or Tie-2); growth-regulated oncogene (GRO)-α
GRO-β and GRO-γ; matrix metalloproteinase-1; tissue inhibitor metalloproteinase-1; and urokinase-type plasminogen activator surface receptor
but lesser amounts of anti-angiogenic tissue inhibitor metalloproteinase-2 and pro-inflammatory monocyte chemoattractant protein-1. At concentrations from 0.62 to 10 μg/ml
the exosomes from 3D-SFnws-cultured HDFs proved their angiogenic power by inducing HDMVECs to form significant amounts of tubes in vitro.ConclusionsThe structural and mechanical properties of carded/hydroentangled 3D-SFnws proved their suitability for tissue engineering and regeneration applications. Consistent with our hypothesis
3D-SFnws-adhering HDFs released exosomes carrying several AGFs that induced HDMVECs to promptly assemble vascular tubes in vitro. Hence
we posit that once implanted in vivo
the 3D-SFnws/HDFs interactions could promote the vascularization and repair of extended skin wounds due to burns or other noxious agents in human and veterinary clinical settings.
关键词
Keywords
Silk fibroinNonwovensDermisFibroblastHuman endothelial cellExosomeCytokineChemokineAngiogenesisRegenerationTissue engineering
references
1.Guo C, Zhang J, Jordan JS, Wang X, Henning RW, Yarger JL. Structural comparison of various silkworm silks: an insight into the structure-property relationship. Biomacromolecules. 2018;19:906–17.
2.Altman GH, Diaz F, Jakuba C, Calabro T, Horan RL, Chen J, et al. Silk-based biomaterials. Biomaterials. 2003;24:401–16.
3.Thurber AE, Omenetto FG, Kaplan DL. In vivo bioresponses to silk proteins. Biomaterials. 2015;71:145–57.
4.Rockwood DN, Preda RC, Yücel T, Wang X, Lovett ML, Kaplan DL. Materials fabrication from Bombyx mori silk fibroin. Nat Protoc. 2011;6:1612–31.
5.Li C, Guo C, Fitzpatrick V, Ibrahim A, Zwierstra MJ, Hanna P, et al. Design of biodegradable, implantable devices towards clinical translation. Nat Rev Mat. 2020;5:61–81.
6.Holland C, Numata K, Rnjak-Kovacina J, Seib FP. The biomedical use of silk: past, present, future. Adv Healthc Mater. 2019. https://doi.org/10.1002/adhm.201800465.
7.Edana, the voice of nonwovens. At: https://www.edana.org/docs/default-source/edana-nonwovens/iso-and-cen-definition-of-nonwovens.pdf?sfvrsn=21822973_221.
8.Dal Prà I, Freddi G, Minic J, Chiarini A, Armato U. De novo engineering of reticular connective tissue in vivo by silk fibroin nonwoven materials. Biomaterials. 2005;26:1987–99.
9.Dal Prà I, Chiarini A, Boschi A, Freddi G, Armato U. Novel dermo-epidermal equivalents on silk fibroin-based formic acid-crosslinked three-dimensional nonwoven devices with prospective applications in human tissue engineering/regeneration/repair. Int J Mol Med. 2006;18:241–7.
10.Chiarini A, Freddi G, Liu D, Armato U, Dal Prà I. Biocompatible silk noil-based three-dimensional carded-needled nonwoven scaffolds guide the engineering o novel skin connective tissue. Tissue Eng Part A. 2016;22:1047–60.
11.Smith RS, Smith TJ, Blieden TM, Phipps RP. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol. 1997;151:317–22.
12.Witowski J, Thiel A, Dechend R, Dunkel K, Fouquet N, Bender TO, et al. Synthesis of C-X-C and C-C chemokines by human peritoneal fibroblasts: induction by macrophage-derived cytokines. Am J Pathol. 2001;158:1441–50.
13.Bang C, Thum T. Exosomes: new players in cell-cell communication. Int J Biochem Cell Biol. 2012;44:2060–4.
14.Grimstad Ø, Sandanger Ø, Ryan L, Otterdal K, Damaas JK, Pukstad B, et al. Cellular sources and inducers of cytokines present in acute wound fluid. Wound Repair Regen 2011;19:337–47.
15.Cvikl B, Lussi A, Moritz A, Sawada K, Gruber R. Differential inflammatory response of dental pulp explants and fibroblasts to saliva. Int Endod J. 2016;49:655–62.
16.Ohta K, Naruse T, Kato H, Ishida Y, Nakagawa T, Ono S, et al. Differential regulation by IFN-γ on TNF-α-induced chemokine expression in synovial fibroblasts from temporomandibular joint. Mol Med Rep. 2017;16:6850–7.
17.Tokarz A, Szuścik I, Kuśnierz-Cabala B, Kapusta M, Konkolewska M, Żurakowski A, et al. Extracellular vesicles participate in the transport of cytokines and angiogenic factors in diabetic patients with ocular complications. Folia Med Cracov. 2015;55:35–48.
18.Yan L, Wu X, Wu X. Exosomes produced from 3D cultures of umbilical cord mesenchymal stem cells in a hollow-fiber bioreactor show improved osteochondral regeneration activity. Cell Biol Toxicol. 2020;36:165–78.
19.Hu S, Li Z, Cores J, Huang K, Su T, Dinh PU, et al. Needle-free injection of exosomes derived from human dermal fibroblast spheroids ameliorates skin Photoaging. ACS Nano. 2019;13:11273–82.
20.Fitzgerald W, Freeman ML, Lederman MM, Vasilieva E, Romero R, Margolis L. A system of cytokines encapsulated in extracellular vesicles. Sci Rep. 2018. https://doi.org/10.1038/s41598-018-27190-x.
21.Gurunathan S, Kang MH, Jeyaraj M, Qasim M, Kim JH. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cell. 2019. https://doi.org/10.3390/cells8040307.
22.Hu P, Yang Q, Wang Q, Shi C, Wang D, Armato U, et al. Mesenchymal stromal cells-exosomes: a promising cell-free therapeutic tool for wound healing and cutaneous regeneration. Burns Trauma. 2019. https://doi.org/10.1186/s41038-019-0178-8.
23.Barnes BJ, Somerville CC. Modulating cytokine production via select packaging and secretion from extracellular vesicles. Front Immunol. 2020. https://doi.org/10.3389/fimmu.2020.01040.
24.Shabbir A, Cox A, Rodriguez-Menocal L, Salgado M, Van Badiavas E. Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro. Stem Cells. Dev 2015; 24: 1635–47.
25.Baruah J, Wary KK. Exosomes in the regulation of vascular endothelial cell regeneration. Front Cell Dev Biol. 2020. https://doi.org/10.3389/fcell.2019.00353
26.Edwards JV, Graves E, Prevost N, Condon B, Yager D, Dacorta J, et al. Development of a nonwoven hemostatic dressing based on unbleached cotton: a de novo design approach. Pharmaceutics. 2020. https://doi.org/10.3390/pharmaceutics12070609.
27.Chiarini A, Armato U, Gardenal E, Gui L, Dal Prà I. Amyloid β-exposed human astrocytes overproduce Phospho-tau and Overrelease it within exosomes, effects suppressed by Calcilytic NPS 2143-further implications for Alzheimer's therapy. Front Neurosci. 2017. https://doi.org/10.3389/fnins.2017.00217.
28.Patel GK, Khan MA, Zubair H, Srivastava SK, Khushman M, Singh S, et al. Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications. Sci Rep. 2019. https://doi.org/10.1038/s41598-019-41800-2.
29.Nakamura K, Jinnin M, Harada M, Kudo H, Nakayama W, Inoue K, et al. Altered expression of CD63 and exosomes in scleroderma dermal fibroblasts. J Dermatol Sci. 2016;84:30–9.
30.Armato U, Romano F, Andreis PG, Paccagnella L, Marchesini C. Growth stimulation and apoptosis induced in cultures of neonatal rat liver cells by repeated exposures to epidermal growth factor/urogastrone with or without associated pancreatic hormones. Cell Tissue Res. 1986;245:471–80.
31.Zhang K, Mo X, Huang C, He C, Wang H. Electrospun scaffolds from silk fibroin and their cellular compatibility. J Biomed Mater Res A. 2010;93:976–983.
32.Lotz B, Colonna Cesari F. The chemical structure and the crystalline structures of Bombyx mori silk fibroin. Biochimie. 1979;61:205.
33.Holzapfel GA. Biomechanics of soft tissue in. In: Lemaitre J (ed). Handbook of Materials Behavior Models. Burlington:Academic Press, 2001, 1057–71.
34.Wang Y, Rudym DD, Walsh A, Abrahamsen L, Kim HJ, Kim HS, et al. In vivo degradation of three-dimensional silk fibroin scaffolds. Biomaterials. 2008;29:3415–28.
35.Huang R, Jiang W, Yang J, Mao YQ, Zhang Y, Yang W, et al. A biotin label-based antibody array for high-content profiling of protein expression. Cancer Genomics Proteomics. 2010;7:129–41.
36.Zhang Y, Chopp M, Zhang ZG, Katakowski M, Xin H, Qu C, et al. Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury. Neurochem Int. 2017;111:69–81.
37.Sun Y, Wang Y, Zhou L, Zou Y, Huang G, Gao G, et al. Spheroid-cultured human umbilical cord-derived mesenchymal stem cells attenuate hepatic ischemia-reperfusion injury in rats. Sci Rep. 2018. https://doi.org/10.1038/s41598-018-20975-0
38.Kim MH, Wu WH, Choi JH, Kim J, Jun JH, Ko Y, et al. Galectin-1 from conditioned medium of three-dimensional culture of adipose-derived stem cells accelerates migration and proliferation of human keratinocytes and fibroblasts. Wound Repair Regen. 2018;26 Suppl 1:S9–18.
39.Martin M, Veloso A, Wu J, Katrukha EA, Akhmanova A. Control of endothelial cell polarity and sprouting angiogenesis by non-centrosomal microtubules. Elife. 2018. https://doi.org/10.7554/eLife.33864.
40.Du P, Suhaeri M, Ha SS, Oh SJ, Kim SH, Park K. Human lung fibroblast-derived matrix facilitates vascular morphogenesis in 3D environment and enhances skin wound healing. Acta Biomater. 2017;54:333–44.
41.Armato U, Dal Pra I, Chiarini A. Freddi. Will silk fibroin nanofiber scaffolds ever hold a useful place in translational regenerative medicine? Int J Burns Trauma. 2011;1:27–33.
42.Mu W, Rana S, Zöller M. Host matrix modulation by tumor exosomes promotes motility and invasiveness. Neoplasia. 2013;15:875–87.
43.Zheng J, Fan H, Chen Y, Ni B, Wang S, Sun M, et al. Expression of MMP-1/PAR-1 and patterns of invasion in oral squamous cell carcinoma as potential prognostic markers. Onco Targets Ther. 2015;8:1619–26.
44.Liu H, Chen B, Lilly B. Fibroblasts potentiate blood vessel formation partially through secreted factor TIMP-1. Angiogenesis. 2008;11:223–34.
45.Mauldin GN, Foster TP, Waddell CW, Egan ME. Cloning, expression and in vitro evaluation of recombinant canine Tum5, an angiostatic domain of mammalian type IV collagen. Vet Comp Oncol. 2003;1:36–47.
46.Vaalamo M, Leivo T, Saarialho-Kere U. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, −2, −3, and −4) in normal and aberrant wound healing. Hum Pathol. 1999;30:795–802.
47.Lu Y, Liu S, Zhang S, Cai G, Jiang H, Su H, et al. Tissue inhibitor of metalloproteinase-1 promotes NIH3T3 fibroblast proliferation by activating p-Akt and cell cycle progression. Mol Cells. 2011;31:225–30.
48.Porter KE, Turner NA, O'Regan DJ, Ball SG. Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. Cardiovasc Res. 2004;64:507–15.
49.Fernández CA, Butterfield C, Jackson G, Moses MA. Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): loop 6 is a novel angiogenesis inhibitor. J Biol Chem. 2003;278:40989–95.
50.Stetler-Stevenson WG, Seo DW. TIMP-2: an endogenous inhibitor of angiogenesis. Trends Mol Med. 2005;11:97–103.
51.Sidenius N, Sier CF, Blasi F. Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo. FEBS Lett. 2000;475:52–6.
52.McMahon BJ, Kwaan HC. Components of the plasminogen-plasmin system as biologic markers for cancer. Adv Exp Med Biol. 2015;867:145–56.
53.Su S-C, Lin C-W, Yang W-E, Fan W-L, Yang S-F. The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies. Expert Opin Ther Targets. 2016;20:551–66.
54.Unseld M, Chilla A, Pausz C, Mawas R, Breuss J, Zielinski C, et al. PTEN expression in endothelial cells is down-regulated by uPAR to promote angiogenesis. Thromb Haemost. 2015;114:379–89.
55.Gerwins P, Sköldenberg E, Claesson-Welsh L. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol. 2000;34:185–94.
56.Preissner KT, Reuning U. Vitronectin in vascular context: facets of a multitalented matricellular protein. Semin Thromb Hemost. 2011;37:408–24.
57.Gondi CS, Lakka SS, Dinh DH, Olivero WC, Gujrati M, Rao JS. Intraperitoneal injection of a hairpin RNA–expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice. Clin Cancer Res. 2007;13:4051–60.
58.Raghu H, Nalla AK, Gondi CS, Gujrati M, Dinh DH. Rao JS. uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM-CSF but dependent on TIMP-1 in endothelial and glioblastoma cells. Mol Oncol. 2012;6:33–47.
59.Cooper F, Overmiller AM, Loder A, Brennan-Crispi DM, McGuinn KP, Marous MR, et al. Enhancement of cutaneous wound healing by Dsg2 augmentation of uPAR secretion. J Invest Dermatol. 2018;138:2470–9.
60.Augustin HG, Koh G-Y. Organotypic vasculature: from descriptive heterogeneity to functional pathophysiology. Science. 2017. https://doi.org/10.1126/science.aal2379.
61.Saharinen P, Leppänen VM, Alitalo K. Snapshot: angiopoietins and their functions. Cell. 2017;171:724–4.
62.Frye M, Dierkes M, Küppers V, Vockel M, Tomm J, Zeuschner D, et al. Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin. J Exp Med. 2015;212:2267–87.
63.Balaji S, Han N, Moles C, Shaaban AF, Bollyky PL, Crombleholme TM, et al. Angiopoietin-1 improves endothelial progenitor cell-dependent neovascularization in diabetic wounds. Surgery. 2015;158:846–56.
64.Kim I, Kim HG, Moon SO, Chae SW, So JN, Koh KN, et al. Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ Res. 2000;86:952–9.
65.Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Circ Res. 2000;86:24–9.
66.Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 2000;407:242–8.
67.Babaei S, Teichert-Kuliszewska K, Zhang Q, Jones N, Dumont DJ, Stewart DJ. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am J Pathol. 2003;162:1927–36.
68.Kim JH, Shin JP, Kim IT, Park DH. Aqueous angiopoietin-like 4 levels correlate with nonperfusion area and macular edema in branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 2016;57:6–11.
69.Korhonen EA, Lampinen A, Giri H, Anisimov A, Kim M, Allen B, et al. Tie1 controls angiopoietin function in vascular remodeling and inflammation. J Clin Invest. 2016;126:3495–510.
70.Chae JK, Kim I, Lim ST, Chung MJ, Kim WH, Kim HG, et al. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol. 2000;20:2573–8.
71.Thurston G. Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage. J Anat. 2002;200:575–80.
72.Gu J, Zhang Y, Han Z, Gao L, Cui J, Sun Y, et al. Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC. Cell Death Dis. 2020;11:367.
73.Kim I, Kim JH, Moon SO, Kwak HJ, Kim NG, Koh GY. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Oncogene. 2000;19:4549–52.
74.Alawo DOA, Tahir TA, Fischer M, Bates DG, Amirova SR, Brindle NPJ. Regulation of angiopoietin signalling by soluble Tie2 ectodomain and engineered ligand trap. Sci Rep. 2017. https://doi.org/10.1038/s41598-017-03981-6.
75.Sanchez B, Li L, Dulong J, Aimond G, Lamartine J, Liu G, et al. Impact of human dermal microvascular endothelial cells on primary dermal fibroblasts in response to inflammatory stress. Front Cell Dev Biol. 2019. https://doi.org/10.3389/fcell.2019.00044.
76.Engelhardt E, Toksoy A, Goebeler M, Debus S, Bröcker EB, Gillitzer R. Chemokines IL-8, GRO alpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol. 1998;153:1849–60.
77.Gibran NS, Ferguson M, Heimbach DM, Isik FF. Monocyte chemoattractant protein-1 mRNA expression in the human burn wound. J Surg Res. 1997;70:1–6.
78.Jackman SH, Yoak MB, Keerthy S, Beaver BL. Differential expression of chemokines in a mouse model of wound healing. Ann Clin Lab Sci. 2000;30:201–7.
79.Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Investig Dermatol. 2007;127:514–25.
80.Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol. 2001;69:513–21.
81.Wong VW, Rustad KC, Akaishi S, Sorkin M, Glotzbach JP, Januszyk M, et al. Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling. Nat Med. 2011;18:148–52.
82.Fahey E, Doyle SLIL. 1 family cytokine regulation of vascular permeability and angiogenesis. Front Immunol. 2019;10:1426.
83.Salmeron K, Aihara T, Redondo-Castro E, Pinteaux E, Bix G. IL-1alpha induces angiogenesis in brain endothelial cells in vitro: implications for brain angiogenesis after acute injury. J Neurochem. 2016;136:573–80.
84.Tang A, Gilchrest BA. Regulation of keratinocyte growth factor gene expression in human skin fibroblasts. J Dermatol Sci. 1996;11:41–50.
85.Lee P, Gund R, Dutta A, Pincha N, Rana I, Ghosh S, et al. Stimulation of hair follicle stem cell proliferation through an IL-1 dependent activation of γδT-cells. Elife. 2017. https://doi.org/10.7554/eLife.28875.
86.Wills-Karp M, Finkelman FD. Untangling the complex web of IL-4- and IL-13-mediated signaling pathways. Sci Signal. 2008. https://doi.org/10.1126/scisignal.1.51.pe55.
87.Li M, Gao L, Chen J, Zhang Y, Wang J, Lu X, et al. Controllable release of interleukin-4 in double-layer sol-gel coatings on TiO2 nanotubes for modulating macrophage polarization. Biomed Mater. 2018. https://doi.org/10.1088/1748-605X/aa9526.
88.Barthes J, Dollinger C, Muller CB, Liivas U, Dupret-Bories A, Knopf-Marques H, et al. Immune assisted tissue engineering via incorporation of macrophages in cell-laden hydrogels under cytokine stimulation. Front Bioeng Biotechnol. 2018. https://doi.org/10.3389/fbioe.2018.00108.
89.Postlethwaite AE, Holness MA, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest. 1992;90:1479–85.
90.Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro L, Elner VM, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992;258:1798–801.
91.Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, et al. The functional role of the ELR motif in CXC chemokine- mediated angiogenesis. J Biol Chem. 1995;270:27348–57.
92.Strieter RM, Burdick MD, Mestas J, Gomperts B, Keane MP, Belperio JA. Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer. 2006;42:768–78.
93.Keane MP, Arenberg DA, Lynch JP, III, Whyte RI, Iannettoni MD, Burdick MD, et al. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol. 1997;159:1437–43.
94.Keane MP, Belperio JA, Burdick MD, Lynch JP, III, Fishbein MC, Strieter RM. ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2001;164:2239–42.
95.Keglowich L, Roth M, Philippova M, Resink T, Tjin G, Oliver B, et al. Bronchial smooth muscle cells of asthmatics promote angiogenesis through elevated secretion of CXC-chemokines (ENA-78, GRO-α, and IL-8). PLoS One. 2013. https://doi.org/10.1371/journal.pone.0081494.
96.Dawson TC, Lentsch AB, Wang Z, Cowhig JE, Rot A, Maeda N, et al. Exaggerated response to endotoxin in mice lacking the Duffy antigen/re- ceptor for chemokines (DARC). Blood. 2000;96:1681–4.
97.Horton LW, Yu Y, Zaja-Milatovic S, Strieter RM, Richmond A. Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth. Cancer Res. 2007;67:9791–9.
98.Ramjeesingh R, Leung R, Siu CH. Interleukin-8 secreted by endothelial cells induces chemotaxis of melanoma cells through the chemokine receptor CXCR1. FASEB J. 2003;17:1292–4.
99.Pausch TM, Aue E, Wirsik NM, Freire Valls A, Shen Y, Radhakrishnan P, et al. Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes. Sci Rep. 2020. https://doi.org/10.1038/s41598-020-62416-x.
100.Tanaka R, Umeyama Y, Hagiwara H, Ito-Hirano R, Fujimura S, Mizuno H, et al. Keloid patients have higher peripheral blood endothelial progenitor cell counts and CD34+ cells with normal vasculogenic and angiogenic function that overexpress vascular endothelial growth factor and interleukin-8. Int J Dermatol. 2019;58:1398–405.
101.Bachmann S, Jennewein M, Bubel M, Guthörl S, Pohlemann T, Oberringer M. Interacting adipose-derived stem cells and microvascular endothelial cells provide a beneficial milieu for soft tissue healing. Mol Biol Rep. 2020;47:111–22.
102.Zaja-Milatovic S, Richmond A. CXC chemokines and their receptors: a case for a significant biological role in cutaneous wound healing. Histol Histopathol. 2008;23:1399–407.
103.Christopherson K III, Hromas R. Chemokine regulation of normal and pathologic immune responses. Stem Cells. 2001;19:388–96.
104.Chinnici CM, Pietrosi G, Iannolo G, Amico G, Cuscino N, Pagano V, et al. Mesenchymal stromal cells isolated from human fetal liver release soluble factors with a potential role in liver tissue repair. Differentiation. 2019;105:14–26.
105.Lisi S, Sisto M, Lofrumento DD, D’Amore M, De Lucro R, Ribatti D. A potential role of the GRO-α/CXCR2 system in Sjögren's syndrome: regulatory effects of pro-inflammatory cytokines. Histochem Cell Biol. 2013;139:371–9.
106.Sajadi SM, Khoramdelazad H, Hassanshahi G, Rafatpanah H, Hosseini J, Mahmoodi M, et al. Plasma levels of CXCL1 (GRO-alpha) and CXCL10 (IP-10) are elevated in type 2 diabetic patients: evidence for the involvement of inflammation and angiogenesis/angiostasis in this disease state. Clin Lab. 2013;59:133–7.
107.Girbl T, Lenn T, Perez L, Rolas L, Barkaway A, Thiriot A, et al. Distinct compartmentalization of the chemokines CXCL1 and CXCL2 and the atypical receptor ACKR1 determine discrete stages of neutrophil diapedesis. Immunity. 2018;49:1062, e6–76.
108.Tsou PS, Rabquer BJ, Ohara RA, Stinson WA, Campbell PL, Amin MA, et al. Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines. Rheumatology (Oxford). 2016;55:745–54.
0
Views
0
下载量
0
CSCD
- L-PDFDownload
- Meta-XMLDownload
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Publicity Resources
Related Articles
Related Author
Related Institution
- Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19
京公网安备11010802024621 - It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
- Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
